Using Continuous Glucose Monitoring for Kidney Transplant Patients
Use of CGM in Kidney Transplant Recipients
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 80 (estimated)
- Sponsor
- University of California, Davis · Other
This trial is looking for kidney transplant patients with type 2 diabetes who are on insulin. Participants will use a continuous glucose monitor to help manage their blood sugar levels over time.
You may be able to join if
- I am 18 years or older.
- I received a kidney transplant within the past year.
- I have functioning kidney function (eGFR > 30 mL/min).
- I have type 2 diabetes and I use insulin.
- I have access to a home wi-fi connection.
You may not be able to join if
- I have type 1 diabetes.
- I take hydroxyurea.
- I cannot wear the Dexcom G6 device all the time.
- I cannot test my blood glucose 4 times a day.
- I have significant visual or cognitive impairment.
- I am illiterate.
- I am a prisoner.
- I am pregnant, planning to become pregnant, or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
Loading trial locations…